This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The treatment of Behcet's syndrome can be divided into:

  • topical steroids - for mucocutaneous ulcers and uveitis
    • commonly used as monotherapy or in combination with immunosuppressants
  • systemic steroids - usually required at some stage
  • steroid-sparing drugs - azathioprine may be used in conjunction with steroids; alternative steroid-sparing agents include cyclosporin

Reference:

  1. Nair JR, Moots RJ. Behcet’s disease. Clin Med (Lond). 2017 Feb;17(1):71-77. Doi: 10.7861/clinmedicine.17-1-71. PMID: 28148585; PMCID: PMC6297594.
  2. Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, de Vincentiis M, Lambiase A. Behçet's disease: New insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018 Jun;17(6):567-575.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.